TY - JOUR
T1 - Genetic diagnosis of Duchenne and Becker muscular dystrophy through mRNA analysis :
T2 - New splicing events
AU - Segarra Casas, Alba
AU - Domínguez-González, C
AU - Hernández-Laín, Aurelia
AU - Sanchez-Calvin, Maria Teresa
AU - Camacho, Ana
AU - Rivas, Eloy
AU - Campo-Barasoain, Andrea
AU - Madruga, Marcos
AU - Ortez, Carlos
AU - Natera-De Benito, Daniel
AU - Nascimento, Andrés
AU - Codina, Anna
AU - Rodriguez, Maria Jose
AU - Gallano, Pia
AU - González-Quereda, Lidia
PY - 2023
Y1 - 2023
N2 - Background Up to 7% of patients with Duchenne muscular dystrophy (DMD) or Becker muscular dystrophy (BMD) remain genetically undiagnosed after routine genetic testing. These patients are thought to carry deep intronic variants, structural variants or splicing alterations not detected through multiplex ligation-dependent probe amplification or exome sequencing. Methods RNA was extracted from seven muscle biopsy samples of patients with genetically undiagnosed DMD/BMD after routine genetic diagnosis. RT-PCR of the DMD gene was performed to detect the presence of alternative transcripts. Droplet digital PCR and whole-genome sequencing were also performed in some patients. Results We identified an alteration in the mRNA level in all the patients. We detected three pseudoexons in DMD caused by deep intronic variants, two of them not previously reported. We also identified a chromosomal rearrangement between Xp21.2 and 8p22. Furthermore, we detected three exon skipping events with unclear pathogenicity. Conclusion These findings indicate that mRNA analysis of the DMD gene is a valuable tool to reach a precise genetic diagnosis in patients with a clinical and anatomopathological suspicion of dystrophinopathy that remain genetically undiagnosed after routine genetic testing.
AB - Background Up to 7% of patients with Duchenne muscular dystrophy (DMD) or Becker muscular dystrophy (BMD) remain genetically undiagnosed after routine genetic testing. These patients are thought to carry deep intronic variants, structural variants or splicing alterations not detected through multiplex ligation-dependent probe amplification or exome sequencing. Methods RNA was extracted from seven muscle biopsy samples of patients with genetically undiagnosed DMD/BMD after routine genetic diagnosis. RT-PCR of the DMD gene was performed to detect the presence of alternative transcripts. Droplet digital PCR and whole-genome sequencing were also performed in some patients. Results We identified an alteration in the mRNA level in all the patients. We detected three pseudoexons in DMD caused by deep intronic variants, two of them not previously reported. We also identified a chromosomal rearrangement between Xp21.2 and 8p22. Furthermore, we detected three exon skipping events with unclear pathogenicity. Conclusion These findings indicate that mRNA analysis of the DMD gene is a valuable tool to reach a precise genetic diagnosis in patients with a clinical and anatomopathological suspicion of dystrophinopathy that remain genetically undiagnosed after routine genetic testing.
U2 - 10.1136/jmg-2022-108828
DO - 10.1136/jmg-2022-108828
M3 - Article
C2 - 36535754
SN - 1468-6244
VL - 60
SP - 615
EP - 619
JO - Journal of Medical Genetics
JF - Journal of Medical Genetics
IS - 6
ER -